Clinical Trials for Secondary Progressive Multiple Sclerosis

Find clinical trials for secondary progressive multiple sclerosis. Discover research opportunities and treatment options in your area.

7 Active Trials Found

Showing 7 trials on this page

Page 1 of 1

A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients

NCT ID: NCT06292923

This clinical trial is studying a new treatment called nasal foralumab for patients with non-active secondary progressive multiple sclerosis (SPMS). Foralumab is a type of medicine designed to help...

Recruiting

Phase: PHASE2 Type: interventional Locations: Boston, Massachusetts, United States, Worcester, Massachusetts, United States +5 more

Cladribine Tablets as an Exit Therapy Strategy

NCT ID: NCT06887426

This clinical trial is studying the use of Cladribine Tablets (CladT) as a potential last treatment option for older adults with Multiple Sclerosis (MS), specifically those with Relapsing Remitting...

Not yet recruiting

Type: observational Locations: Strasbourg, , France

Metformin Treatment in Progressive Multiple Sclerosis

NCT ID: NCT05349474

This clinical trial is studying the safety of a medication called metformin for people with progressive forms of multiple sclerosis (MS), specifically Secondary Progressive and Primary Progressive ...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Los Angeles, California, United States

Functional Outcomes From Diets in Multiple Sclerosis

NCT ID: NCT05327322

This clinical trial is looking at how two different diet plans might help people with multiple sclerosis (MS) feel better and improve their daily lives. Specifically, the study will test a diet tha...

Recruiting

Phase: NA Type: interventional Locations: Birmingham, Alabama, United States, Saint Louis, Missouri, United States

A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

NCT ID: NCT06372145

This clinical trial is investigating the long-term safety and tolerability of a medication called tolebrutinib for adults with different types of Multiple Sclerosis (MS), including relapsing forms ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Seoul, Seoul Teukbyeolsi, Korea, Republic Of, Santiago, Reg Metropolitana De Santiago, Chile +348 more

Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

NCT ID: NCT04047628

The BEAT-MS trial is studying two different treatment options for people with severe relapsing multiple sclerosis (MS) who haven't responded well to other therapies. The two treatments being compar...

Recruiting

Phase: PHASE3 Type: interventional Locations: Rochester, Minnesota, United States, Durham, North Carolina, United States +21 more

SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis

NCT ID: NCT03783416

The SIZOMUS trial is studying the safety and effectiveness of a medication called ixazomib (also known as NINLARO) for people with different types of multiple sclerosis (MS), including relapsing-re...

Recruiting

Phase: PHASE1 Type: interventional Locations: London, Greater London, United Kingdom

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions